Saved in:
| Main Authors: | Rui Lan, Lina Mao, Tingting Luo, Wenjin Luo, Yao Qin, Hanwen Ye, Jingbo Hu, Shuming Yang, Qifu Li, Zhihong Wang, Xiangjun Chen |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.70107 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Socioeconomic Status, Modifiable Factors, and Risk of Microvascular Complications in Individuals With Type 2 Diabetes: A Cohort Study From the UK Biobank
by: Ying Li, et al.
Published: (2025)
by: Ying Li, et al.
Published: (2025)
Diabetes, glycaemic traits and cardiovascular disease in females and males: Observational and Mendelian randomisation analyses in the UK Biobank
by: Sophie C. de Ruiter, et al.
Published: (2025)
by: Sophie C. de Ruiter, et al.
Published: (2025)
Sex‐Specific Associations of Inflammatory Biomarkers With All‐Cause and Cardiovascular Mortality Across Glycaemic Status: A Prospective UK Biobank Study
by: Yawen Zhang, et al.
Published: (2026)
by: Yawen Zhang, et al.
Published: (2026)
Global Prevalence of Microvascular Complications in Children and Adolescents With Type 1 and Type 2 Diabetes: A Systematic Review and Meta‐Analysis
by: Yasmin Ezzatvar, et al.
Published: (2025)
by: Yasmin Ezzatvar, et al.
Published: (2025)
Causal Association Between Cholesterol‐Lowering Drugs and Diabetic Microvascular Complications: A Drug‐Target Mendelian Randomization Study
by: Bo Yang, et al.
Published: (2025)
by: Bo Yang, et al.
Published: (2025)
Cardiovascular Therapy Benefits of Novel Antidiabetic Drugs in Patients With Type 2 Diabetes Mellitus Complicated With Cardiovascular Disease: A Network Meta‐Analysis
by: Saixian Shi, et al.
Published: (2025)
by: Saixian Shi, et al.
Published: (2025)
The Role of Serum Free Fatty Acids in Endothelium‐Dependent Microvascular Function
by: Alexander E. Sullivan, et al.
Published: (2025)
by: Alexander E. Sullivan, et al.
Published: (2025)
Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort
by: Manrong Xu, et al.
Published: (2025)
by: Manrong Xu, et al.
Published: (2025)
Association Between Serum Advanced Glycation End Products and Cardiovascular‐Kidney‐Metabolic (CKM) Syndrome: A 3‐Year Longitudinal Cohort Study (2019–2022)
by: Hui Zhao, et al.
Published: (2025)
by: Hui Zhao, et al.
Published: (2025)
Dietary Fibre, Gut Microbiota and Cardiovascular Outcomes: Differential Associations by Diabetes Status in Multiethnic Cohorts
by: Yuwei Li, et al.
Published: (2026)
by: Yuwei Li, et al.
Published: (2026)
Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
by: Jiayuan He, et al.
Published: (2024)
by: Jiayuan He, et al.
Published: (2024)
Clustering‐based risk stratification of prediabetes populations: Insights from the Taiwan and UK Biobanks
by: Djeane Debora Onthoni, et al.
Published: (2024)
by: Djeane Debora Onthoni, et al.
Published: (2024)
Disentangling the relationship between glucose, insulin and brain health: A UK Biobank study
by: Andrew C. Mason, et al.
Published: (2025)
by: Andrew C. Mason, et al.
Published: (2025)
NET‐Related Gene as Potential Diagnostic Biomarkers for Diabetic Tubulointerstitial Injury
by: Yufeng Liang, et al.
Published: (2024)
by: Yufeng Liang, et al.
Published: (2024)
Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank
by: Seyedeh Forough Sajjadi, et al.
Published: (2024)
by: Seyedeh Forough Sajjadi, et al.
Published: (2024)
Sleep Phenotypes, Genetic Susceptibility, and Risk of Obesity in Patients With Type 2 Diabetes: A National Prospective Cohort Study
by: Lei Xi, et al.
Published: (2025)
by: Lei Xi, et al.
Published: (2025)
Cardiovascular Outcomes With SGLT‐2 Inhibitors in Patients With Type 2 Diabetes and Obstructive Sleep Apnoea: A Real‐World Analysis
by: Reuben L. Odai, et al.
Published: (2026)
by: Reuben L. Odai, et al.
Published: (2026)
Diabetes UK 2024 Author Index
Published: (2024)
Published: (2024)
Associations of Stressful Life Events With Diabetes Incidence in China: Insights From the China Kadoorie Biobank
by: Jing Qian, et al.
Published: (2025)
by: Jing Qian, et al.
Published: (2025)
Metabolomic network reveals novel biomarkers for type 2 diabetes mellitus in the UK Biobank study
by: Jiahao Liu, et al.
Published: (2025)
by: Jiahao Liu, et al.
Published: (2025)
Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank
by: Wenxiao Fan, et al.
Published: (2025)
by: Wenxiao Fan, et al.
Published: (2025)
Associations of metabolic syndrome with cognitive function and dementia risk: Evidence from the UK Biobank cohort
by: Qianlin Zuo, et al.
Published: (2024)
by: Qianlin Zuo, et al.
Published: (2024)
Evolution of Cardiovascular Risk Factors Related to BMI and Metabolic Control in Children and Adolescents With Type 1 Diabetes Mellitus: A Cohort Study
by: Daniella Rodriguez Curval, et al.
Published: (2025)
by: Daniella Rodriguez Curval, et al.
Published: (2025)
Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
by: Yuanjie Mao, et al.
Published: (2024)
by: Yuanjie Mao, et al.
Published: (2024)
Ketogenic Diet, Serum Ketone Bodies and Risk of End‐Stage Renal Disease in Patients With Diabetic Kidney Disease: A Multi‐Cohort Study
by: Ke Liu, et al.
Published: (2025)
by: Ke Liu, et al.
Published: (2025)
Association of glycaemic control with intraocular pressure in a large general population: Results from the UK Biobank
by: Qiaoling Liu, et al.
Published: (2024)
by: Qiaoling Liu, et al.
Published: (2024)
Individual and joint associations of obesity and metabolic health parameters on arterial stiffness: Evidence from the UK Biobank
by: Roshan A. Ananda, et al.
Published: (2024)
by: Roshan A. Ananda, et al.
Published: (2024)
Response to Commentary on “Sleep Phenotypes, Genetic Susceptibility, and Risk of Obesity in Patients With Type 2 Diabetes: A National Prospective Cohort Study”
by: Lei Xi, et al.
Published: (2025)
by: Lei Xi, et al.
Published: (2025)
HMBG-1: A Biomarker in the Management of Diabetic Retinopathy
by: Burak Bilgin
Published: (2024)
by: Burak Bilgin
Published: (2024)
Comment on “Time Trends in Cardiovascular Event Incidence in New‐Onset Type 2 Diabetes: A Population‐Based Cohort Study From Germany”
by: Saraswati Sah, et al.
Published: (2025)
by: Saraswati Sah, et al.
Published: (2025)
Application and Progression of Single‐Cell RNA Sequencing in Diabetes Mellitus and Diabetes Complications
by: Jiajing Hong, et al.
Published: (2025)
by: Jiajing Hong, et al.
Published: (2025)
Diabetes Complications among Inpatients with Childhood and Young Adult–Onset Type 1 and 2 Diabetes
by: Kate Hawke, et al.
Published: (2024)
by: Kate Hawke, et al.
Published: (2024)
Commentary on “Association of Serum Total Bilirubin to Cholesterol Ratio With Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes: A Retrospective Cohort Study”
by: Tinghua Zhang
Published: (2025)
by: Tinghua Zhang
Published: (2025)
Coronary Calcium Scoring in Diabetes: Recalibrating Cardiovascular Risk in 2025
by: Kyvan Irannejad, et al.
Published: (2025)
by: Kyvan Irannejad, et al.
Published: (2025)
Cause‐specific death in adults with type 1 diabetes and type 2 diabetes: Insights from the UK Biobank
by: John W. Ostrominski, et al.
Published: (2024)
by: John W. Ostrominski, et al.
Published: (2024)
Adiposity indicators exhibit depot‐ and sex‐specific associations with multimorbidity onset: A cohort study of the UK Biobank
by: Lu Ma, et al.
Published: (2024)
by: Lu Ma, et al.
Published: (2024)
Obstructive Sleep Apnoea and Risk of Fragility Fracture in Patients With Type 2 Diabetes: A Population‐Based Retrospective Cohort Study
by: Esraa A. Makhdom, et al.
Published: (2025)
by: Esraa A. Makhdom, et al.
Published: (2025)
The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk
by: Elias John Elenjickal, et al.
Published: (2026)
by: Elias John Elenjickal, et al.
Published: (2026)
Elevated Serum IgA at Onset of Type 1 Diabetes in Children
by: Amruta Thakkar, et al.
Published: (2024)
by: Amruta Thakkar, et al.
Published: (2024)
Author Response to the Comment on “Time Trends in Cardiovascular Event Incidence in New‐Onset Type 2 Diabetes: A Population‐Based Cohort Study From Germany”
by: Theresia Sarabhai, et al.
Published: (2025)
by: Theresia Sarabhai, et al.
Published: (2025)
Similar Items
-
Socioeconomic Status, Modifiable Factors, and Risk of Microvascular Complications in Individuals With Type 2 Diabetes: A Cohort Study From the UK Biobank
by: Ying Li, et al.
Published: (2025) -
Diabetes, glycaemic traits and cardiovascular disease in females and males: Observational and Mendelian randomisation analyses in the UK Biobank
by: Sophie C. de Ruiter, et al.
Published: (2025) -
Sex‐Specific Associations of Inflammatory Biomarkers With All‐Cause and Cardiovascular Mortality Across Glycaemic Status: A Prospective UK Biobank Study
by: Yawen Zhang, et al.
Published: (2026) -
Global Prevalence of Microvascular Complications in Children and Adolescents With Type 1 and Type 2 Diabetes: A Systematic Review and Meta‐Analysis
by: Yasmin Ezzatvar, et al.
Published: (2025) -
Causal Association Between Cholesterol‐Lowering Drugs and Diabetic Microvascular Complications: A Drug‐Target Mendelian Randomization Study
by: Bo Yang, et al.
Published: (2025)